Ryan D. Gentzler, MD, MS Disclosures: Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Pfizer, Inc.|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Amgen|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Dizal|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Chugai|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Merck Merck|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-AstraZeneca AstraZeneca|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Janssen|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Daiichi Sankyo, Inc.|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Takeda|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Jounce Therapeutics|Researcher - principal or named investigator (include even if your institution receives the research grant and manages the funds)-Bristol-Myers Squib Aventis (Relationship has ended)|Consulting Fee-Regeneron (Relationship has ended)|Consulting Fee-Merus (Relationship has ended)|Other: Support for travel to meeting-Tempus (Relationship has ended)|Consulting Fee-AstraZeneca AstraZeneca (Relationship has ended)|Consulting Fee-Mirati (Relationship has ended)|Consulting Fee-Gilead (Relationship has ended)|Consulting Fee-Oncocyte (Relationship has ended) - 05/13/2024 No Bio Available